Earnings Feed
Start Free
Home/Filings/4/0001996104-26-000002
4//SEC Filing

Trahan Jeremy 4

Accession 0001996104-26-000002

CIK 0001729149other
View on SEC.govCompany Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 5:00 PM ET

Size

18.8 KB

Accession

0001996104-26-000002

Research Summary

AI-generated summary of this filing

Updated

Viemed (VMD) GC Jeremy Trahan Exercises Derivatives, Receives Awards

What Happened

  • Jeremy Trahan, General Counsel of Viemed Healthcare (VMD), exercised/converted derivative awards on Jan 17, 2026 and had shares withheld/sold to cover taxes and cash-settled phantom awards. Specifically, the filing shows 4,884 and 1,221 derivative units exercised/converted, with 1,595 shares withheld for taxes (1,595 x $7.33 = $11,691) and 1,221 shares disposed to the issuer for cash settlement (1,221 x $7.33 = $8,950). On Jan 19, 2026 Trahan was granted new awards totaling 62,950 derivative units (50,360 + 12,590) shown as RSUs and phantom-share awards (no cash paid).

Key Details

  • Transaction dates: exercises/conversions and tax withholding/settlements on 2026-01-17; grants on 2026-01-19. Filing date: 2026-01-21.
  • Prices/values: tax-withheld 1,595 shares at $7.33 = $11,691; disposition to issuer 1,221 shares at $7.33 = $8,950. Some derivative exercises are reported with $0 per share (typical for conversions/phantom settlements).
  • Shares owned after these transactions: not specified in the provided filing details.
  • Notable footnotes:
    • RSUs = contingent right to one common share upon vesting (F1, F5, F7).
    • Shares were withheld to satisfy tax obligations from RSU vesting (F2).
    • Phantom shares are cash-settled rights equal to the economic value of one share; settlement is reported as acquisition of underlying shares and simultaneous sale back to the company for cash (F4, F6, F8, F9).
    • Grants dated Jan 19 vest in three equal annual installments beginning on the first anniversary of the grant date (F5, F6, F7, F9).
  • Transaction codes: M = exercise/conversion of derivative; F = tax withholding; D = disposition to issuer (cash settlement); A = award/grant.

Context

  • This was largely administrative: conversion/exercise of derivative awards and tax withholding/cash settlement of phantom units and RSUs, followed by new RSU/phantom grants. The disposals appear to be internal/cash-settlement and tax-related rather than open-market sales; such transactions typically reflect routine vesting and settlement rather than an outright market sale or independent buy signal.

Insider Transaction Report

Form 4
Period: 2026-01-17
VIEMED HEALTHCARE, INC.VMD
Trahan Jeremy
General Counsel
Transactions
  • Exercise/Conversion

    Common Shares

    [F1]
    2026-01-17+4,884→ 30,387 total
  • Tax Payment

    Common Shares

    [F2][F3]
    2026-01-17$7.33/sh−1,595$11,691→ 28,792 total
  • Exercise/Conversion

    Common Shares

    [F4]
    2026-01-17+1,221→ 30,013 total
  • Disposition to Issuer

    Common Shares

    [F3]
    2026-01-17$7.33/sh−1,221$8,950→ 28,792 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F5]
    2026-01-17−4,884→ 0 total
    Exp: 2026-01-17→ Common Shares (4,884 underlying)
  • Exercise/Conversion

    Phantom Share Units

    [F4][F6]
    2026-01-17−1,221→ 0 total
    Exp: 2026-01-17→ Common Shares (1,221 underlying)
  • Award

    Restricted Stock Units

    [F1][F7]
    2026-01-19+50,360→ 50,360 total
    Exp: 2029-01-19→ Common Shares (50,360 underlying)
  • Award

    Phantom Share Units

    [F8][F9]
    2026-01-19+12,590→ 12,590 total
    Exp: 2029-01-19→ Common Shares (12,590 underlying)
Footnotes (9)
  • [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
  • [F2]Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
  • [F3]Per share value is based on the market closing price of the common shares for January 16, 2026.
  • [F4]Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
  • [F5]Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.
  • [F6]Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
  • [F7]Restricted Stock Units (RSUs) granted to reporting person on January 19, 2026, which vest in three equal annual installments beginning on the first anniversary of the grant date.
  • [F8]Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
  • [F9]Represents an award granted on January 19, 2026 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
Signature
/s/ Jesse Bergeron, Attorney-in-Fact|2026-01-21

Documents

1 file

Issuer

VIEMED HEALTHCARE, INC.

CIK 0001729149

→
Entity typeother

Related Parties

1
  • filerCIK 0001996104

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 5:00 PM ET
Size
18.8 KB
View on SEC.gov